Share

April 09, 2013; 80 (15) Article

Molecular and pathologic insights from latent HIV-1 infection in the human brain

Paula Desplats, Wilmar Dumaop, David Smith, Anthony Adame, Ian Everall, Scott Letendre, Ronald Ellis, Mariana Cherner, Igor Grant, Eliezer Masliah
First published March 13, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31828c2e9e
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
579

Share

Article Information

vol. 80 no. 15 1415-1423
DOI: 
https://doi.org/10.1212/WNL.0b013e31828c2e9e
PubMed: 
23486877
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received March 14, 2012
  • Accepted in final form November 29, 2012
  • First Published March 13, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Paula Desplats, PhD,
    2. Wilmar Dumaop, BS,
    3. David Smith, MD,
    4. Anthony Adame, BS,
    5. Ian Everall, PhD,
    6. Scott Letendre, MD,
    7. Ronald Ellis, MD, PhD,
    8. Mariana Cherner, PhD,
    9. Igor Grant, MD and
    10. Eliezer Masliah, MD
  1. Paula Desplats, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. UCSD

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Wilmar Dumaop, BS,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. David Smith, MD,
    4. Scientific Advisory Boards:

    1. Pfizer Scientific Board for HIV medications 2008

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. editorial advisory boardThe Open AIDS Journal 2006 to presentThe Open Infectious Diseases Journal 2008 to present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Consultant and Board MemberSymmunity LLC

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. The investigator is supported by National Institutes ofHealth grants MH083552, AI077304, AI69432, MH62512,AI27670, AI38858, AI43638, AI43752, AI047745, UCSD Centersfor AIDS Research Viral Pathogenesis Core (AI36214)and HIVInfection of the San Diego Veterans Affairs HealthcareSystem (10-92-035) from 2007 to present.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Symmunity LLC

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Anthony Adame, BS,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Ian Everall, PhD,
    6. Scientific Advisory Boards:

    1. Abbott Laboratories Pte Ltd.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Abbott Laboratories Pte Ltd., Commercial, honorariumAstraZeneca, Commercial, honorarium

    Editorial Boards:

    1. Molecular PsychiatryTranslational PsychiatryJournal of VirologyHIV/AIDS - research adn Palliative CareNeurobevioral HIV Medicine

    Patents:

    1. Detection of biomarkers for neuropsychiatric disorders, US20080261218A method comprising: performing a statistical analysis ona first set of gene data expressed in brain tissueobtained from a first control set not having aneuropsychiatric disorder and a second set of gene dataexpressed in central nervous system tissue obtained from afirst set of individuals having a neuropsychiatricdisorder to identify a first set of one or moredifferentially expressed genes; performing a statisticalanalysis on a third set of gene data expressed in bloodobtained from a second control set not having aneuropsychiatric disorder and a fourth set of gene dataexpressed in blood obtained from a second set ofindividuals having a neuropsychiatric disorder to identifya second set of one or more differentially expressedgenes; and comparing the first set of one or moredifferentially expressed genes to the second set of one ormore differentially expressed genes to identify a commonset of one or more differentially expressed genes.

    Publishing Royalties:

    1. Neurology of AIDS, 3rd Edition, OUP 2012

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Abbott Laboratories Pte Ltd.

    Research Support, Government Entities:

    1. National Health and Medical Research Council, AustraliaCommonwealth Government of Australia

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Scott Letendre, MD,
    7. Scientific Advisory Boards:

    1. (1) GlaxoSmithKline, 2011(2) Merck & Co., Inc., 2012

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Lucid Group UK, Speaker Honorarium(2) Stratagen, Speaker Honorarium

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Merck & Co., Inc.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) GlaxoSmithKline, Paid to the University of California(2) Merck & Co., Inc., Paid to the University of California(3) Tibotec/Janssen, Paid to the University of California

    Research Support, Government Entities:

    1. (1) NIH, U01 MH083506, consultant, 2011, 2012(2) NIH, R01 MH58076, co-investigator, 2011, 2012(3) NIH, P01 DA12065, co-investigator, 2011, 2012(4) NIH, R01 MH73433, co-investigator, 2011, 2012(5) NIH, N01 MH22005, co-investigator, 2011, 2012(6) NIH, P30 MH62512, co-investigator, 2011, 2012(7) NIH, R01 MH78748, co-investigator, 2011, 2012(8) NIH, R21 MH85610, principal investigator, 2011, 2012(9) NIH, R01, MH92225, principal investigator, 2011, 2012

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Ronald Ellis, MD, PhD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Abbott International, speaker honoraria

    Editorial Boards:

    1. Journal of Neuroimmune Pharmacology, Editorial Advisory Board, 2007-2010

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NeurogesX, Inc. - Consultant fee for FDA Advisory panel

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH, P30 MH62512, Co-investigator, 2010-2015 (2) NIH, N01 HHSN271201000036C, Co-investigator, 2010-2015(3) NIH, P50 DA26306, Co-investigator, 2009-2014(4) NIH, R01 MH095621, Co-investigator, 2011-2016 (5) NIH, U01 MH83506, Co-investigator, 2008-2013(6) NIH, R01 MH83552, Co-investigator, 2008-2013(7) NIH, R01 MH085608, Co-investigator, 2009-2013(8) NIH, R01 MH94159, Co-investigator, 2011-2016

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. Abbott Laboratories, stock held by spouseJohnson and Johnson, stock held by spouse

    Legal Proceedings:

    1. NONE

  8. Mariana Cherner, PhD,
    9. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. travel to the annual meeting of the InternationalNeuropsychological Society as Chair of a Society committee

    Editorial Boards:

    1. Journal of the International Neuropsychological Society,member of editorial board, 2004-2012

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) NIH, MH81482, PI, 2007-present(2) NIH, DA27513, PI, 2009-2012(3) NIH, DA26334, PI, 2009-2012(4) NIH, MH62512, Co-I, 2006-present(5) NIH, DA26306, Co-I, 2009-present(6) NIH, MH58076, C0-I, 2006-2011

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Igor Grant, MD and
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Abbott Pharmaceuticals speaker fee

    Editorial Boards:

    1. (1)Journal of the International NeuropsychologicalSociety, Associate Editor, 2002-2004, (2) Journal ofNeurovirology, Associate Editor, 2002-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Abbott Pharmaceuticals

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIDA, DA26306, PI, 2009-present, (2) NIMH, MH83506,PI, 2002-present, (3) NIA, AG15301, PI, 2002-present, (4)NIMH, HHSN271201000036C, PI, 2010-present, (5) NIMH,HHSN271201000030C, PI, 2010-present, (6) NIMH, MH62512,Co-I, 2011-present, (7) NIMH, MH78748, Co-I, 2007-present,(8) NIMH, MH83552, Co-I, 2008-present, (9) NIMH, MH094159,Co-I, 2011-present

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. Eliezer Masliah, MD
    11. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. EVER Pharma and NPT sponsored travel to international scientific meeting

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Neotope Biosciences, NPT, Neurophage

    Research Support, Government Entities:

    1. NIH NIA AG5131, AG18440, MH062962, AG043384

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Departments of Neurosciences (P.D., A.A., R.E., E.M.), Pathology (W.D., E.M.), Medicine (D.S., S.L.), and Psychiatry (I.E., M.C., I.G.), University of California San Diego, La Jolla. Dr. Everall is currently affiliated with the Department of Psychiatry, University of Melbourne, Melbourne, Australia.
  1. Correspondence to Dr. Masliah: emasliah{at}ucsd.edu
View Full Text

Article usage

Article usage: March 2013 to December 2020

AbstractFullPdfSource
Mar 2013208126Highwire
Apr 201314182165Highwire
May 20132501429Highwire
Jun 20131262420Highwire
Jul 201372714Highwire
Aug 201358113Highwire
Sep 201378414Highwire
Oct 20136625Highwire
Nov 20134736Highwire
Dec 20135221Highwire
Jan 20147003Highwire
Jan 201432414pmc
Feb 20143621Highwire
Mar 20144844Highwire
Apr 20145056Highwire
May 20142710Highwire
Jun 20142200Highwire
Jul 20143314Highwire
Aug 20141832Highwire
Sep 20142933Highwire
Oct 20143013Highwire
Nov 20143402Highwire
Dec 20141933Highwire
Jan 20153412Highwire
Jan 201502212pmc
Feb 20152211Highwire
Feb 201501817pmc
Mar 20153632Highwire
Mar 20150156pmc
Apr 20152433Highwire
Apr 20150116pmc
May 20152221Highwire
May 2015087pmc
Jun 20152101Highwire
Jun 20150148pmc
Jul 20153422Highwire
Jul 20150106pmc
Aug 20152821Highwire
Aug 20150178pmc
Sep 20152700Highwire
Sep 20150158pmc
Oct 20151911Highwire
Oct 20150158pmc
Nov 20152701Highwire
Nov 2015093pmc
Dec 20152411Highwire
Dec 2015063pmc
Jan 20163810Highwire
Jan 20160189pmc
Feb 20164701Highwire
Feb 20160104pmc
Mar 20161701Highwire
Mar 2016073pmc
Apr 20161921Highwire
Apr 2016084pmc
May 20161224Highwire
May 20160137pmc
Jun 20163011Highwire
Jun 201601511pmc
Jul 20162220Highwire
Jul 20160197pmc
Aug 20162711Highwire
Aug 2016072pmc
Sep 20162000Highwire
Sep 20160124pmc
Oct 20163020Highwire
Oct 20160133pmc
Nov 20162234Highwire
Nov 2016074pmc
Dec 20161810Highwire
Dec 201601512pmc
Jan 20171900Highwire
Jan 2017070pmc
Feb 20172310Highwire
Feb 2017062pmc
Mar 20172310Highwire
Mar 20170145pmc
Apr 20172620Highwire
Apr 201711112pmc
May 20171600Highwire
May 201761114pmc
Jun 20171400Highwire
Jun 2017156pmc
Jul 20171401Highwire
Jul 201791212pmc
Aug 20171011Highwire
Aug 2017388pmc
Sep 20171000Highwire
Sep 2017297pmc
Oct 20171433Highwire
Oct 2017699pmc
Nov 20171800Highwire
Nov 201761010pmc
Dec 20171203Highwire
Jan 2018610Highwire
Feb 2018700Highwire
Mar 20182442Highwire
Apr 20181900Highwire
Apr 201851011pmc
May 20181900Highwire
Jun 2018901Highwire
Jun 201831110pmc
Jul 2018811Highwire
Aug 20181700Highwire
Aug 2018599pmc
Sep 20182013Highwire
Oct 20182000Highwire
Nov 2018900Highwire
Dec 20181100Highwire
Jan 20191022Highwire
Feb 20191402Highwire
Mar 20192100Highwire
Apr 20193001Highwire
May 20192232Highwire
Jun 20192500Highwire
Jul 20192001Highwire
Aug 20192700Highwire
Sep 20191500Highwire
Oct 20191600Highwire
Nov 20192421Highwire
Dec 20192101Highwire
Jan 20202110Highwire
Feb 20201524Highwire
Mar 20202211Highwire
Apr 20202510Highwire
May 20201323Highwire
Jun 20201411Highwire
Jul 20201700Highwire
Aug 20201300Highwire
Sep 20201810Highwire
Oct 20201220Highwire
Nov 20202810Highwire
Dec 20201121Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me